Case History: JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

被引：13
|
作者：
Weber, Ann E. [1 ]
Thornberry, Nancy [2 ]
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42007-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：95 / 109
页数：15
相关论文
共 50 条
  • [1] Discovery of JANUVIA™ (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type2 diabetes
    Thornberry, Nancy A.
    Weber, Ann E.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 557 - 568
  • [2] Sitagliptin: A dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Miller, Shannon A.
    St. Onge, Erin L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1336 - 1343
  • [3] The asymmetric synthesis of Sitagliptin, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Liu, Feng
    Yu, Wansheng
    Ou, Wenhua
    Wang, Xiaoke
    Ruan, Libo
    Li, Yiming
    Peng, Xijiang
    Tao, Xiaohu
    Pan, Xianhua
    JOURNAL OF CHEMICAL RESEARCH, 2010, (04) : 230 - 232
  • [4] JANUVIA® and beyond: Selective dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
    Weber, Ann E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [5] Sitagliptin - The first dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (09) : 434 - +
  • [6] Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Gallwitz, Baptist
    IDRUGS, 2008, 11 (12) : 906 - 917
  • [7] Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (04) : 402 - 413
  • [8] MK-0431 is a potent, selective, dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Weber, AE
    Kim, D
    Beconi, M
    Eiermann, G
    Fisher, M
    He, HB
    Hickey, G
    Jagpal, S
    Leiting, B
    Lyons, K
    Marsilio, F
    McCann, P
    Moller, D
    Patel, R
    Petrov, A
    Pryor, K
    Roy, RS
    Wu, J
    Wyvratt, M
    Zhang, BB
    Thornberry, NA
    DIABETES, 2004, 53 : A151 - A151
  • [9] Discovery of MK-0431, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Weber, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2642 - U2643
  • [10] Vildagliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (10) : 494 - +
12345